LSA
PCRX icon

Leonteq Securities AG’s Pacira BioSciences PCRX Stock Holding History

Leonteq Securities AG’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-260
Closed -$10.6K – 1293
2023
Q1 		$10.6K Hold
260
– – ﹤0.01% 1016
2022
Q4 		$10K Hold
260
– – ﹤0.01% 1055
2022
Q3 		$13.8K Hold
260
– – ﹤0.01% 1010
2022
Q2 		$15.2K Hold
260
– – ﹤0.01% 1021
2022
Q1 		$19.8K Hold
260
– – ﹤0.01% 1007
2021
Q4 		$15.6K Buy
+260
New +$14.3K ﹤0.01% 1102

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Leonteq Securities AG's PCRX Position: Q2 2023 in Review

Leonteq Securities AG sold out of Pacira BioSciences (PCRX) in Q2 2023, closing a stake of 260 shares — an estimated $10.6K sold.

Leonteq Securities AG first reported a position in PCRX in Q4 2021 and held it in 6 quarters. The position peaked at $19.8K in Q1 2022. 258 funds tracked by Wall St. Rank hold PCRX as of Q2 2023.

  • Leonteq Securities AG reported no remaining Pacira BioSciences position as of Q2 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 260 Pacira BioSciences shares in Q2 2023, an estimated $10.6K.
  • Leonteq Securities AG first reported a position in Pacira BioSciences in Q4 2021 and held it in 6 quarters.
  • Leonteq Securities AG's Pacira BioSciences position peaked at $19.8K in Q1 2022.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2023.

Based on Leonteq Securities AG's 13F filing for Q2 2023, filed 11 Mar 2026.